Ginkgolic acid and anacardic acid are reversible inhibitors of SARS-CoV-2 3-chymotrypsin-like protease

Abstract Because of the emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in different regions of the world, the battle with infectious coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has been seesawing. Therefore, the identification of antiviral drugs is of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dongsheng Li, Gangan Yan, Wenwen Zhou, Shuyi Si, Xiaoping Liu, Jing Zhang, Yan Li, Yunyu Chen
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2022-05-01
Colecção:Cell & Bioscience
Assuntos:
SARS-CoV-2
3CL protease inhibitor
Non-covalent
Reversible
Mixed-inhibition manner
Ginkgolic acid
Acesso em linha:https://doi.org/10.1186/s13578-022-00806-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados